Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Hydromorphone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 7 Neoplasms 3 Pain, Postoperative 2 Malignant Female Reproductive System Neoplasm 2 Hematologic Neoplasms 2 Emergencies 2 Agnosia 2 Uterine Cervical Neoplasms 1 Tumor Surgery 1 Sarcoma 1 Rectal Neoplasms 1 Pulmonary Nodule 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Ovarian Neoplasms 1 Neuralgia 1 Neoplasm Metastasis 1 Mucositis 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Intraoperative Complications 1 Ileus 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Duodenal Neoplasms 1 Diverticulosis, Colonic 1

Interventions

Sorafenib 42 Bevacizumab 26 Oxaliplatin 21 Radiosurgery 19 Gemcitabine 17 Fluorouracil 15 lenvatinib 12 Hepatectomy 12 Radiofrequency Ablation 11 Nivolumab 11 Cisplatin 11 Radiotherapy 10 Doxorubicin 10 Capecitabine 10 durvalumab 9 Leucovorin 9 Blood Specimen Collection 9 atezolizumab 8 Liver Transplantation 8 Everolimus 7 Electroporation 7 pembrolizumab 6 camrelizumab 6 Sunitinib 6 Immunohistochemistry 6 Cyclophosphamide 6 Cryosurgery 6 Carboplatin 6 tremelimumab 5 sintilimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡